"High rate of linezolid intermediate susceptibility and resistance among enteric vancomycin-resistant Enterococcus (VRE) recovered from hospitalized patients actively screened for VRE colonization" by Thomas J Dilworth

Selected Works of David Kramer, MD, FACP

Article

High rate of linezolid intermediate susceptibility and resistance among enteric vancomycin-resistant Enterococcus (VRE) recovered from hospitalized patients actively screened for VRE colonization

Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America

Thomas J Dilworth, Advocate Aurora Health
Eric T Beck, Advocate Aurora Health
Rachel Pedersen, Advocate Aurora Health
Waseem G Al-Karkokly, Advocate Aurora Health
Margaret Cook, Advocate Aurora Health
Erika Aldag, Advocate Aurora Health
David Kramer, Advocate Aurora Health
ajay sahajpal, Advocate Aurora Health
Iram Nadeem, Advocate Aurora Health
Brian P Buggy, Advocate Aurora Health
Charles F Brummitt, Advocate Aurora Health

Link

Affiliations

Department of Pharmacy Services, Department of Abdominal Transplant, Department of Critical Care Medicine, Infectious Diseases Section, Aurora St Luke's Medical Center

Publication Date

7-1-2019

Document Type

Article

PubMed ID

31088583

Citation Information

Dilworth TJ, Beck ET, Pedersen RA, et al. High rate of linezolid intermediate susceptibility and resistance among enteric vancomycin-resistant Enterococcus (VRE) recovered from hospitalized patients actively screened for VRE colonization. Infect Control Hosp Epidemiol. 2019; 40(7):821-822. doi: 10.1017/ice.2019.116.